ZAVZPRET ONESOURCE Trademark

Trademark Overview


On Monday, April 24, 2023, a trademark application was filed for ZAVZPRET ONESOURCE with the United States Patent and Trademark Office. The USPTO has given the ZAVZPRET ONESOURCE trademark a serial number of 97903135. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, August 6, 2024. This trademark is owned by Pfizer Ireland Pharmaceuticals. The ZAVZPRET ONESOURCE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information to healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies, and patient financial assistance; healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing patient financial assistance for prescription drugs and free trial program for prescription drugs

business administration of patient insurance reimbursement programs

Providing medical information on the topics of migraine and treatment of migraine; providing medical information on the topics of migraine and treatment of migraine via a call center
zavzpret onesource

General Information


Serial Number97903135
Word MarkZAVZPRET ONESOURCE
Filing DateMonday, April 24, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding information to healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies, and patient financial assistance; healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing patient financial assistance for prescription drugs and free trial program for prescription drugs
Goods and Servicesbusiness administration of patient insurance reimbursement programs
Goods and ServicesProviding medical information on the topics of migraine and treatment of migraine; providing medical information on the topics of migraine and treatment of migraine via a call center

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, May 21, 2023
Primary Code035
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, May 21, 2023
Primary Code036
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 21, 2023
Primary Code044
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History


Party NamePfizer Ireland Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRingaskiddy, Co. Cork
IE

Trademark Events


Event DateEvent Description
Sunday, May 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 27, 2023NEW APPLICATION ENTERED
Friday, January 19, 2024TEAS AMENDMENT OF USE RECEIVED
Saturday, January 20, 2024USE AMENDMENT FILED
Saturday, January 20, 2024AMENDMENT TO USE PROCESSING COMPLETE
Monday, January 22, 2024ASSIGNED TO EXAMINER
Thursday, February 1, 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, January 31, 2024USE AMENDMENT ACCEPTED
Tuesday, April 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, August 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 7, 2024NON-FINAL ACTION E-MAILED